1.Lack of multi-organ carcinogenesis in female N:GP(S) mice by benzo(a) pyrene, dimethylnitrosamine and dibutylnitrosamine.
Yoon Sil LEE ; Kyung Ja CHO ; Ja Joon JANG
Journal of the Korean Cancer Association 1993;25(4):572-577
No abstract available.
Animals
;
Carcinogenesis*
;
Dimethylnitrosamine*
;
Female*
;
Humans
;
Mice*
2.Postirradiation Malignant Mixed Mesodermal Tumor of the Uterus: A case report.
Na Hye MYONG ; Kyung Ja CHO ; Sang Yoon PARK ; Ja June JANG
Korean Journal of Pathology 1990;24(2):161-165
A case of malignant mixed mesodermal tumor (MMMT) developed after radiation therapy for a uterine cervix cancer is described. The patient was a 62-year-old female at the time of diagnosis of stage Ib squamous cell carcinoma of the cervix and a total of 12,000 rads of x-ray was administered on the pelvic area. Five years later she manifested vaginal spotting and rectal pain. Endometial curettage and biopsy revealed carcinosarcoma. Radical hysterectomy was done and a 5x3x2 cm sized polypoid mass was noted in the uterine cavity. Microscopically, the tumor showed intimate admixture of adenocarcinomatous and sarcomatous areas. The sarcomatous stroma was composed of compactly arranged atypical spindle cells with frequent mitoses, merging into a loosely textured reticular areas and abundant amount of heterologous elements such as skeletal muscle and cartilage. The rhabdomyosarcomatous element was confirmed by PTAH staining and immunohistochemical staining for myoglobin and desmin. Multiple metastases to the liver, lung, and lymph nodes appeared within one year of total abdominal hysterectomy and bilateral salpingo-oophorectomy. In spite of palliative radiotherapy, she expired one month later.
Female
;
Humans
;
Biopsy
;
Neoplasm Metastasis
3.Pathological observations in locally advanced gastric carcinomas after preoperative chemotherapy.
Kyung Ja CHO ; Ja June JANG ; Chang Won HA ; Jae Soo KOH ; Jong In LEE ; Dong Wook CHOI ; Yoon Koo KANG
Journal of the Korean Cancer Association 1992;24(4):541-548
No abstract available.
Drug Therapy*
4.Oxyphilic Clear Cell Carcinoma of the Ovary: A case report.
Chang Won HA ; Jae Soo KOH ; Na Hye MYOUNG ; Kyung Ja CHO ; Sang Yoon PARK ; Mi Kyung KIM ; Ja June JANG
Korean Journal of Pathology 1992;26(5):500-503
Oxyphilic clear cell carcinoma of the ovary is a variant of clear cell carcinoma with abundant eosinophilic cytoplasm described by Young & Scully in 1987. Thorough samplin is needed to identify typical foci of clear cell carcinoma for the differential diagnoses from a variety of ovarian tumors with oxyphilic cells. We report a case of oxyphilic clear cell carcinoma in a 65-year-old female patient who presented with vaginal spotting and lower abdominal discomfort. The excised mass was a 10x8x7cm sized, well circumscribe yellowish white solid ovarian tumor. Microscopically, the tumor showed glandular, papillary and alveolar growth patterns composed of cuboidal or hobnail-shaped oxyphilic cells.
Female
;
Humans
;
Diagnosis, Differential
5.Primary squamous cell carcinoma of thyroid gland with local recurrence: ultrasonographic and computed tomographic findings.
Ja Yoon JANG ; Kye Won KWON ; Sang Wook KIM ; Inyoung YOUN
Ultrasonography 2014;33(2):143-148
Primary squamous cell carcinoma of the thyroid gland (PSCCT) is a rare malignancy that presents with advanced disease and poor prognosis. It is difficult to diagnose PSCCT in its early stage because of its rarity and lack of typical imaging findings. We experienced an elderly woman with PSCCT confirmed by surgery. Although preoperative fine-needle aspiration revealed no malignancy, surgical resection was performed because the ultrasonogram showed diffuse microcalcifications, which suggested malignancy, and clinically, the mass grew rapidly to compress the trachea. Local tumor recurrence was noted at 3 months after surgery. Surgical resection or repeat biopsy should be considered if a cytologically benign thyroid mass shows imaging or clinical features of malignancy.
Aged
;
Biopsy
;
Biopsy, Fine-Needle
;
Carcinoma, Squamous Cell*
;
Female
;
Humans
;
Neoplasm Recurrence, Local
;
Prognosis
;
Recurrence*
;
Thyroid Gland*
;
Trachea
;
Ultrasonography
6.Prevalence of atrial fibrillation in general population in Kangwon Province.
Myoung Kuk JANG ; Ja Young LEE ; Seong Gyun KIM ; Kyu Heung CHO ; Yong Sang YANG ; Dong Seok YOON ; Sung Heon CHAE
Journal of the Korean Academy of Family Medicine 2001;22(2):178-183
BACKGROUND: Atrial fibrillation is the commonest arrhythmia seen in clinical practice. However, there have been no epidemiologic data on its prevalence in general population of Korea. We performed this study to investigate the prevalence of atrial fibrillation in Korea. METHODS: From March 1, 1999 to July 31, 2000, Kangwon Branch, Korea Association of Health (KAH) parformed electrocardiograms to investigate the health status in the general public in Kangwon Province. We analyzed these data by of chi square(2) test. RESULTS: A total of 45,133 persons participated in the health screening performed by KAH. The number of persons above 40 years old were 13,768, with men and women 6,367 (46.2%) and 7,401 (53.8%)respectively. Prevalence among those above 40 years old was 0.72% and the prevalence among men, 0.96% (61 persons) was significantly higher than that of women, 0.51% (38 persons)(p<0.01). In the group above 60 years old with the prevalence of 1.24%, a similar phenomenon was observed with 1.57% (40 persons) in men and 0.97% (29 persons) in women (p<0.05). CONCLUSION: Prevalence of atrial fibrillation became higher as age increased, specifically in persons older than 40 years.
Adult
;
Arrhythmias, Cardiac
;
Atrial Fibrillation*
;
Electrocardiography
;
Female
;
Gangwon-do*
;
Humans
;
Korea
;
Male
;
Mass Screening
;
Middle Aged
;
Prevalence*
7.Control of Refractory Ascites by Dialytic Ultrafiltration in Patients with Advanced Liver Cirrhosis.
Sang Jin HAN ; Eui Hun JEONG ; Gwang Ho BAIK ; Dong Seok YOON ; Myung Bin KIM ; Moon Soo KOH ; Ja Ryong KOO ; Ung Ki JANG ; Dong Jun KIM
Korean Journal of Medicine 1997;53(5):628-635
BACKGROUND: Currently the most common treatment modality of refractory ascites in patients with liver cirrhosis was large volume paracentesis, but this procedure usually needed albumin infusion and occasionally developed unwanted complications. By reason of albumin shortage in Korea and occasional unfavorable complications, we studied the usefulness of dialytic ultrafiltration as an another treatment modality of refractory ascites. METHODS: Dialytic ultrafiltration was done in 10 patients (total 48 times) with liver cirrhosis or hepatocellular carcinoma. Two drainage conduit (via 16 gauge angio-catheter) of input and output were made by puncture of patient's right and left lower quadrant abdomen. The initial ultrafiltration rate of dialyser was 250mL/min. Ascitic fluid was removed continuously until the filtration rate down at 50mL/min. After ultrafiltration, ascitic fluid contained concentrated albumin and large molecules was reinfused via input conduit. Pre-treatment and post-treatment level of blood chemistry, plasma renin concentration, aldosterone, and electrolytes in serum; total protein and albumin in ascites were measured. During the ultrafiltration, we closely observed the change of blood pressure, heart rates and mental status. RESULTS: The mean ultrafiltration time was 231+/-28min, ultrafiltrated volume was 5.15+/-1.41 L. During dialytic ultrafiltration, patient's blood pressure and heart rate were stable and there was no change of mental status. After dialytic ultrafiltration, blood urea nitrogen level significantly decreased from 30.5+/-23.7mg/dL to 25.7+/-20.2mg/dL; serum aldosterone level decreased from 807.3+/-301.1pg/ml to 431.1+/-187.2pg/ml in serum (P<0.01). The albumin level in the ascitic fluid significantly increased from 0.67+/-0.28g/dL to 1.90+/-1.16g/dL (P<0.01). Plasma renin concentration level tend to decreased (P=0.06). The patient's serum total protein, albumin, electrolytes, and creatinine were not changed. Complications of dialytic ultrafiltration were peritonitis (one case) and hypotension (one case). But these unwanted complications were readily managed by adequate antibiotics and intravenous fluid therapy. CONCLUSION: The dialytic ultrafiltration can be used effectively without albumin infusion in the treatment of refrartory ascites in patients with advanced liver cirrhosis.
Abdomen
;
Aldosterone
;
Anti-Bacterial Agents
;
Ascites*
;
Ascitic Fluid
;
Blood Pressure
;
Blood Urea Nitrogen
;
Carcinoma, Hepatocellular
;
Chemistry
;
Creatinine
;
Drainage
;
Electrolytes
;
Filtration
;
Fluid Therapy
;
Heart Rate
;
Humans
;
Hypotension
;
Korea
;
Liver Cirrhosis*
;
Liver*
;
Paracentesis
;
Patient Rights
;
Peritonitis
;
Plasma
;
Punctures
;
Renin
;
Ultrafiltration*
8.Expression of the G1-S Modulators in Hepatitis B Virus-Related Hepatocellular Carcinoma and Dysplastic Nodule: Association of Cyclin D1 and p53 Proteins with the Progression of Hepatocellular Carcinoma.
Yoon La CHOI ; Seong Hoe PARK ; Ja June JANG ; Cheol Keun PARK
Journal of Korean Medical Science 2001;16(4):424-432
Deranged expression of cell cycle modulators has been reported to contribute to the development and progression of hepatocellular carcinoma (HCC). However, their expression patterns remain poorly understood in hepatitis B virus (HBV)-related HCC, which constitutes about 65-70% of HCC in Korea. The aims of this study were to evaluate the expressions of G1-S modulators in HBV-related HCCs and dysplastic nodules (DNs), and to correlate with the histopathologic features of HCCs. Immunohistochemical expressions of cyclin D1, cyclin E, p53, p27, p21, p16, Rb, and PCNA proteins were investigated in 80 HCCs and 22 DNs. Cyclin D1 overexpression showed positive relationships with advanced tumor stage, poor differentiation, larger tumor size, microvascular invasion, intrahepatic meta-stasis, no tumor capsule formation, infiltrative growth, aberrant p53 expression, and high PCNA labeling index (LI) of HCC (p<0.05). Aberrant p53 expression showed positive relationship with poor differentiation of HCC (p<0.01). Expression of cyclin D1 or p53 was not observed in DNs. The p27 LI and p16 LI were lower in HCCs with intrahepatic metastasis (p<0.05). Cyclin D1 overexpression and aberrant p53 expression could be associated with the progression of HBV-related HCC, and might have a less crucial role in the DN-HCC sequence. In addition, elevated expression of p27 and p16 proteins might have inhibitory action to the intrahepatic metastasis of HBV-related HCC.
Adult
;
Aged
;
Carcinoma, Hepatocellular/chemistry/etiology/*pathology
;
Cyclin D1/*analysis
;
Female
;
G1 Phase
;
Hepatitis B/*complications
;
Human
;
Immunohistochemistry
;
Liver Neoplasms/chemistry/etiology/*pathology
;
Male
;
Microfilament Proteins/analysis
;
Middle Age
;
Precancerous Conditions/*virology
;
Proliferating Cell Nuclear Antigen/analysis
;
Protein p16/analysis
;
Protein p53/*analysis
;
Retinoblastoma Protein/analysis
;
S Phase
10.Altered expression of thioredoxin reductase-1 in dysplastic bile ducts and cholangiocarcinoma in a hamster model.
Byung IL YOON ; Dae Yong KIM ; Ja June JANG ; Jeong Hee HAN
Journal of Veterinary Science 2006;7(3):211-216
Thioredoxin reductase 1 (TrxR) is a homodimeric selenoenzyme catalyzing thioredoxin (Trx) in an NADPHdependent manner. With regard to carcinogenesis, these redox proteins have been implicated in cell proliferation, transformation and anti-apoptosis. In the present study, using a hamster cholangiocarcinoma (ChC) model, we evaluated the immunohistochemical expression pattern of TrxR in precancerous lesions and ChCs as well as in normal bile ducts. The goal of this study was to determine the potential role and importance of TrxR in cholangiocarcinogenesis. For the ChC model, we obtained liver tissue specimens with dysplastic bile ducts prior to the development of ChC 8 weeks after initiation of the experiment and ChC samples at 27 weeks. The immunohistochemical analysis showed diffuse cytoplasmic overexpression of TrxR in the dysplastic bile duct epithelial cells as well as in cholangiocarcinoma; this was comparable to the negative or weakly positive in normal and type 1 hyperplastic bile ducts. However, TrxR appeared to be considerably down-regulated in the ChCs when compared to the higher expression observed in the dysplastic bile ducts. Therefore, these results suggest that TrxR overexpression followed by down-regulation might be an important event in cholangiocarcinogenesis, especially at early stages including the cellular transformation of candidate bile ducts. Further studies are however required to determine whether TrxR may be a potential target molecule for chemoprevention against cholangiocarcinogenesis. In addition, the molecular mechanism as well as the importance of the loss of TrxR in the development of cholangiocarcinoma, following dysplastic transformation of bile duct cells, also remains to be clarified.
Animals
;
Bile Duct Neoplasms/*enzymology/pathology
;
Bile Ducts/enzymology/pathology
;
Cholangiocarcinoma/*enzymology/pathology
;
Cricetinae
;
Disease Models, Animal
;
Immunohistochemistry
;
Mesocricetus
;
Precancerous Conditions/*enzymology/pathology
;
Thioredoxin Reductase (NADPH)/*biosynthesis